// App-Quantinova.ai

7016 : A mixed methods study exploring the role of perceived side effects on treatment decision-making in older adults with acute myeloid leukemia (AML).

Researchers

Presenter

  • Dawn Maze

Principal Investigators

  • Roland B. Walter

  • Diana M. Merino

  • Timothy J. Bell

  • Louise O'Hara

  • Francois Peloquin

  • Lucy Morgan

  • Loriana Hernandez

  • Jasmine Healy

  • Charlotte Panter

  • Verna L. Welch

  • Adam Gater

  • Karim Amer

  • Ryan Hohman

  • Julia Stein

  • Andrew Brown

  • Nigel H. Russell

  • Thomas William LeBlanc

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Canada.

  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

  • Friends of Cancer Research, Washington, DC

  • Pfizer Inc, New York, NY

  • Adelphi Values, Cheshire, United Kingdom

  • Pfizer Canada Inc, Kirkland, QC, Canada

  • ArmorUp for LIFE, Philadelphia, PA

  • Pfizer Inc, New York, NY

  • Pfizer Inc., Tadworth, United Kingdom

  • Department of Virology, Royal Free Hospital, London, United Kingdom

  • Duke University College of Medicine, Durham, NC

Locations

  • Canada

  • United States

  • United Kingdom

Companies

  • Pfizer Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved